What happened
Samil Pharmaceutical disclosed convertible bonds to raise US$6.59M, about 5.3% of its market value.
For context, this raise equals about 5.3% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$6.59M |
| vs. market value | 5.3% |
| Filed | 2026-06-11, Material event report (convertible bonds) |
| Source | DART rcept 20260611000446 → open original filing |
Source: DART. Information only, not investment advice.